ArticleStroke and vascular neurology2024

Rationale and design of Tenecteplase Reperfusion Therapy in Acute Ischaemic Cerebrovascular Events III (TRACE III): a randomised, phase III, open-label, controlled trial.

Yunyun Xiong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.